Tuesday, September 1, 2026 SourcesAbout🌓
🇨🇦 CA ▾
BREAKING
Business

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

Financial Post ·

New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans SAN DIEGO, Sept.

01, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

More in Business

See all ›